Get the Stockscreener App
377.99
1.78%
-6.84
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Chemed Corp stock is traded at $377.99, with a volume of 523.98K.
It is down -1.78% in the last 24 hours and down -20.49% over the past month.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
See More
Previous Close:
$384.83
Open:
$383.97
24h Volume:
523.98K
Relative Volume:
2.61
Market Cap:
$5.20B
Revenue:
$2.53B
Net Income/Loss:
$265.24M
P/E Ratio:
20.58
EPS:
18.3669
Net Cash Flow:
$325.48M
1W Performance:
-5.94%
1M Performance:
-20.49%
6M Performance:
-16.42%
1Y Performance:
-37.17%
1-Day Range:
$377.11
$386.48
1-Week Range:
$376.18
$406.17
52-Week Range:
$376.18
$623.61
Chemed Corp Stock (CHE) Company Profile
Name
Chemed Corp
Sector
Industry
Phone
(513)762-6690
Address
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
377.99 | 5.20B | 2.53B | 265.24M | 325.48M | 18.37 |
HCA
Hca Healthcare Inc
|
493.88 | 110.42B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.35 | 17.42B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
200.08 | 11.63B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
185.82 | 11.35B | 17.36B | 1.51B | 849.25M | 23.15 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Sep-02-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-25-25 | Initiated | Jefferies | Hold |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Buy |
| Oct-12-18 | Initiated | BofA/Merrill | Buy |
| Aug-28-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jul-27-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-02-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-26-15 | Reiterated | Oppenheimer | Outperform |
| Oct-26-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-22-15 | Reiterated | Oppenheimer | Outperform |
| Jul-27-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-19-15 | Reiterated | Oppenheimer | Outperform |
| Sep-23-14 | Reiterated | Oppenheimer | Outperform |
| Jun-10-14 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-01-14 | Reiterated | Oppenheimer | Outperform |
| Sep-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-04-11 | Reiterated | Barclays Capital | Underweight |
| Feb-17-11 | Reiterated | Oppenheimer | Outperform |
| Feb-17-11 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Chemed Corp Stock (CHE) Latest News
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Chemed at Oppenheimer Conference: Navigating Growth and Challenges By Investing.com - Investing.com Australia
Chemed at Oppenheimer Conference: Navigating Growth and Challenges - Investing.com
Chemed Corp stock hits 52-week low at $384.57 By Investing.com - Investing.com India
Chemed Corp stock hits 52-week low at $384.57 - Investing.com
Chemed (NYSE:CHE) Hits New 12-Month LowTime to Sell? - MarketBeat
WBI Investments LLC Makes New $2.36 Million Investment in Chemed Corporation $CHE - MarketBeat
3 Motives to Sell CHE and One Alternative Stock Worth Buying - Bitget
Precision Trading with Chemed Corp (CHE) Risk Zones - Stock Traders Daily
Chemed Corporation $CHE Stock Position Lowered by Algert Global LLC - MarketBeat
Chemed Corporation (NYSE:CHE) Short Interest Down 20.0% in February - MarketBeat
Chemed Corp Stock (ISIN: US1638321034) Under Pressure After CEO Share Sale Amid Undervaluation Signa - AD HOC NEWS
Chemed Corp Stock (ISIN: US1638321034) Under Pressure After CEO Share Sale and Mixed Earnings - AD HOC NEWS
Aristotle Capital Boston LLC Acquires 3,737 Shares of Chemed Corporation $CHE - MarketBeat
Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock - MarketBeat
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares, retains 93,719 - Stock Titan
Insider Kevin McNamara signals sale via Form 144 — Chemed (NYSE: CHE) - Stock Titan
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference - Bluefield Daily Telegraph
First Trust Advisors LP Grows Stock Position in Chemed Corporation $CHE - MarketBeat
Chemed: Expanding Hospice Reach Through Strategic Certificate Of Need Wins In Florida! - Smartkarma
Chemed (NYSE:CHE) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Technical Reactions to CHE Trends in Macro Strategies - Stock Traders Daily
Chemed Corporation $CHE Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed Corporation $CHE Shares Purchased by Bahl & Gaynor Inc. - MarketBeat
Chemed Corporation Receives 'Hold' Rating from Analysts - National Today
Chemed Corp. Stock Hits Day Low of $385 Amid Price Pressure - Markets Mojo
Chemed Corp (CHE) Stock Analysis: Navigating A Stable Healthcare Giant with 8% Upside Potential - DirectorsTalk Interviews
Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Chemed Corp. Faces Weak Start with 14% Gap Down Amid Market Concerns - Markets Mojo
Chemed Corp. Stock Plummets to New 52-Week Low at $385.00 - Markets Mojo
CHE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Chemed Q4 Earnings Call Highlights - Yahoo Finance
CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash - Yahoo Finance
Chemed Corporation (NYSE:CHE) Q4 2025 Earnings Call Transcript - Insider Monkey
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns By Investing.com - Investing.com South Africa
RBC Capital cuts Chemed stock rating on Roto-Rooter margin concerns - Investing.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops By Investing.com - Investing.com South Africa
Chemed Corp stock hits 52-week low at 397.05 USD By Investing.com - Investing.com Australia
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Why Chemed (CHE) Shares Are Plunging Today - Yahoo Finance
Chemed (CHE) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Chemed Corp misses Q4 2025 estimates, stock drops - Investing.com
VITAS Takes a Punch in Q4 2025, Expects Brighter 2026 - Hospice News
Chemed (NYSE:CHE) Reaches New 52-Week Low After Earnings Miss - MarketBeat
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook By Investing.com - Investing.com Canada
BofA downgrades Chemed stock rating on weaker Roto-Rooter outlook - Investing.com
Chemed Corp stock hits 52-week low at 397.05 USD - Investing.com
Chemed Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
TD Asset Management Inc Has $135.14 Million Stake in Chemed Corporation $CHE - MarketBeat
Chemed: Fourth Quarter Earnings Overview - Bitget
Chemed Corp Stock (CHE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):